Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05282550
PHASE2
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
Sponsor: Johns Hopkins University
View on ClinicalTrials.gov
Summary
To investigate the effect of trazodone on sleep, hippocampal-dependent memory and hippocampal excitability. The investigators hypothesize that trazodone will improve total sleep time and proportion of time in Slow Wave Sleep (SWS).
Official title: RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-02-02
Completion Date
2028-06-30
Last Updated
2025-09-18
Healthy Volunteers
No
Interventions
DRUG
Trazodone
50mg of trazodone administered for 4 weeks.
DRUG
Placebo
Placebo administered for 4 weeks.
Locations (1)
Johns Hopkins Hospital
Baltimore, Maryland, United States